Breast Imaging Market Size, Share, By Product (Mammography, Ultrasound, MRI, Thermography, Saige-Q Software, Quantra Software, Mirai Software, and Others), Type (Ionizing Breast Imaging and Nonionizing Breast Imaging), End Users (Hospitals & Clinics, Diag

Breast Imaging Market Size, Share, By Product (Mammography, Ultrasound, MRI, Thermography, Saige-Q Software, Quantra Software, Mirai Software, and Others), Type (Ionizing Breast Imaging and Nonionizing Breast Imaging), End Users (Hospitals & Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, and Breast Care Centers), and Region - Trends, Analysis, and Forecast till 2035

Breast imaging is a procedure used to detect early breast cancer, tumor and cysts with the help of techniques, such as x-rays, sound waves and magnetic resonance imagining to create images of the breast. The target market is expected to rise in upcoming years due to increasing prevalence of breast cancer and technological innovations.

Breast Imaging Market Report Highlights:

By 2035, the target market is expected to increase at a rate of USD 9.9 Billion.

In 2024, breast imaging market size was valued at worth USD 4.9 Billion.

The market is expanding at a 7.3% CAGR.

On the basis of product, the mammography segment holds the largest breast imaging market share.

Based on type, the nonionizing breast imaging segment is expected to witness highest growth during the forecast period.

The hospitals and clinics end-user segment is dominating the market.

North America is projected to experience highest CAGR growth during the forecast period.

Asia Pacific is second most dominating region in the market.

Key Benefits of Purchasing This Report

Gain valuable insights into revenue projections for the overall market and its sub-segments, benefiting industry leaders and new entrants.

Enhance your understanding of the competitive landscape to refine business positioning and optimize go-to-market strategies.

Stay informed on the latest trends in the Blood Oxygen Sensor Market, including key drivers, challenges, opportunities, and barriers.

Breast Imaging Market Report Analysis:

Mammography– Screening mammography is a specific type of breast imaging that uses low-dose x-rays to detect cancer early – before women experience symptoms – when it is most treatable.

Benefits and Risks of Screening Mammography-

Benefits

Screening mammography reduces the risk of death due to breast cancer. It is useful for detecting all types of breast cancer, including invasive ductal and invasive lobular cancer.

Screening mammography improves a physician's ability to detect small tumors. When cancers are small, the woman has more treatment options.

The use of screening mammography increases the detection of small abnormal tissue growths confined to the milk ducts in the breast, called ductal carcinoma in situ (DCIS).

No radiation stays in your body after an x-ray exam.

X-rays usually have no side effects in the typical diagnostic range for this exam.

Risks

There is always a slight chance of cancer from excessive exposure to radiation. However, given the small amount of radiation used in medical imaging, the benefit of an accurate diagnosis far outweighs the associated risk.

The radiation dose for this procedure varies. See the Radiation Dose page for more information.

False Positive Mammograms. Five percent to 15 percent of screening mammograms require more testing such as additional mammograms or ultrasound. Most of these tests turn out to be normal. If there is an abnormal finding, a follow-up or biopsy may have to be performed. Most of the biopsies confirm that no cancer was present. It is estimated that a woman who has yearly mammograms between ages 40 and 49 has about a 30 percent chance of having a false-positive mammogram at some point in that decade and about a 7 percent to 8 percent chance of having a breast biopsy within the 10-year period.

Women should always tell their doctor and x-ray technologist if they are pregnant.

Segmentation:

By Product:

Mammography

Ultrasound

MRI Thermography

Saige-Q Software

Quantra Software

Mirai Software

Others

By Type:

Ionizing Breast Imaging

Nonionizing Breast Imaging

By End-user:

Hospitals and Clinics

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Breast Care Centers

By Region:

North America

U.S.

Canada

Europe

Germany

U.K.

France

Russia

Italy

Spain

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

Australia

Indonesia

Malaysia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

Middle East & Africa

GCC

Israel

South Africa

Rest of Middle East & Africa

Breast Imaging Market Competitive Landscape:

CMR Naviscan

Delphinus Medical Technologies, Inc.

Dilon Technologies

KUBTEC

Hologic, Inc.

CANON MEDICAL SYSTEMS CORPORATION

Planmed Oy

Micrima

Carestream Health

Hologic, Inc.

SonoCine

GE Healthcare

Siemens Healthineers

Koninklijke Philips N.V

AURORA HEALTHCARE US CORP

Key Questions Answered in This Report

1. What was the size of the Blood Oxygen Sensor Market in 2024?

2. What is the expected growth rate of the Blood Oxygen Sensor Market during 2025-2035?

3. What are the key factors driving the Blood Oxygen Sensor Market?

4. What is the breakup of the Blood Oxygen Sensor Market based on the distribution channel?

5. What are the key regions in the Blood Oxygen Sensor Market?

6. Who are the key players/companies in the Blood Oxygen Sensor Market?

7. What are the drivers, restraints, and opportunities in the Blood Oxygen Sensor Market?